“Production of SARS-CoV-2 Pseudotyped Viral Particles for the Evaluation of New Therapies Against COVID-19”. 2022. FAVE Sección Ciencias Veterinarias 20 (Suppl.): 44-50. https://doi.org/10.14409/favecv.2021.Suppl. 44-50.